The increased usage of dried blood spot (DBS) for antibody diagnostic tests for infectious or inflammatory illnesses is predicted to drive growth in the market for dried blood spot collection cards. Dried blood spots make processing, analysis, and quick, accurate diagnosis possible. In situations where laboratory infrastructure is limited, it also demonstrates to be a simpler substitute to plasma-based screening, fostering market expansion over the course of the projection year.
